Bharat Parenterals Ltd.

View in App
350.00 +10.40 ▲3.1%

01 June 2023, 04:01:00 PM
Volume: 614

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bplindia.in
Market Cap 199.17 Cr.
Enterprise Value(EV) 238.93 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 28.38 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 12.33 Trailing Twelve Months Ending 2023-03
Industry PE 32.05 Trailing Twelve Months Ending 2023-03
Book Value / Share 316.55 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.11 Calculated using Price: 350.00
Dividend Yield 0.22 Period Ending 2022-03
No. of Shares Subscribed 0.58 Cr. 5,774,666 Shares
FaceValue 10
About Bharat Parenterals Ltd.
The company is engaged in to the business of the Pharmaceuticals & Drugs.

Bharat Parenterals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Bharat Parenterals Ltd. Performance

View details >>
1 Day
+3.06%
1 Week
-2.79%
1 Month
+5.41%
3 Month
+1.45%
6 Month
-9.77%
1 Year
-7.16%
2 Year
-23.46%
5 Year
+73.27%
10 Year

Bharat Parenterals Ltd. Fundamental Ratios

View details >>
7 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 11.38 11.45 13.35 25.47 22.76 15.53 13.46
Return on Capital Employed (%) 14.23 11.47 18.10 39.30 30.83 20.24 17.18
Return on Assets (%) 5.37 5.99 7.61 14.71 13.94 10.52 9.80

Bharat Parenterals Ltd. Balance Sheet

View details >>
Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 57 64 73 94 118 144 166 183
Non Curr. Liab. 7 3 0 4 3 11 14 13
Curr. Liab. 56 43 57 61 66 44 42 120
Minority Int. 0 4 35
Equity & Liab. 120 110 130 159 188 199 226 350
Non Curr. Assets 49 46 39 41 56 51 82 166
Curr. Assets 72 64 91 118 132 148 144 184
Misc. Exp. not W/O
Total Assets 120 110 130 159 188 199 226 350

Bharat Parenterals Ltd. Profit and Loss

View details >>
Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 124 111 137 220 228 205 212 218
Other Income 5 8 7 13 12 9 8 12
Total Income 129 119 144 232 240 213 220 230
Total Expenditure -114 -105 -124 -191 -201 -179 -184 -198
PBIDT 15 14 19 42 40 34 36 32
Interest -1 -1 -1 -1 -1 -1 -1 -2
Depreciation -4 -6 -6 -6 -6 -6 -7 -6
Taxation -3 -1 -4 -13 -9 -7 -7 -8
Exceptional Items
PAT 6 7 9 21 24 20 21 16
Minority Interest 0 0 1
Share Associate
Other Related Items
Consolidated Net Profit 6 7 9 21 24 20 21 16
Adjusted EPS 11 12 16 37 42 36 36 28

Bharat Parenterals Ltd. Cash Flow

View details >>
Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -2 6 20 14 24 -1
Cash Fr. Inv. -2 -8 -9 -13 -43 -7
Cash Fr. Finan. -8 4 -4 -3 11 9
Net Change -11 2 7 -1 -8 2
Cash & Cash Eqvt 2 4 11 10 2 3

Bharat Parenterals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 74.42 74.42 74.42 74.42 73.84 73.84 73.84 73.84 73.84
Public 25.58 25.58 25.58 25.58 26.16 26.16 26.16 26.16 26.16
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bharat Parenterals Ltd. Announcements

View details >>
Tue, 30 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to SEBI Circular no. CIR/CFD/CMD1/27/2019 dated February 8 2019 read with Exchange Circular no. 20230316-14 dated March 16 2023 please find enclosed herewith the Annual Secretarial Compliance Report of the Company issued by M/s Jigar Trivedi & Co. Practicing Company Secretaries of the Company for the financial year ended 31st March 2023. We request you to kindly take the same on record.
Tue, 23 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Extracts of the newspaper publications published in Business Standard and Loksatta Jansattta on 22nd May 2023 relating to the Audited Standalone and Consolidated Financial Results for the for the quarter and year ended on 31st March 2023. Request you to please take the same on record.
Sat, 20 May 2023
Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended On 31St March 2023
In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company in its meeting held on 20th May 2023 has considered and approved the Audited Financial Results for the Quarter and year ended 31st March 2023 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. The Board has also recommended payment of final dividend of Rs. 0.75 (Rupees Seventy-Five Paise Only) per Equity Share of Rs. 10/- each (fully paid-up) for the financial year ended March 31 2023 and the same shall be payable subject to approval of the Shareholders at the ensuing Annual General Meeting (AGM) of the Company.

Bharat Parenterals Ltd. Technical Scans

View details >>
Thu, 01 Jun 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Crossing 200 SMA From Below Close Crossing 200 SMA From Below
Bullish Harami Bullish Harami

Bharat Parenterals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,934.33 987.50 +1.1%
Divi's Laboratories Ltd. 93,571.04 3,524.75 +2.1%
Cipla Ltd. 77,836.62 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. 75,790.17 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. 69,284.07 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. 60,079.14 1,775.15 -3.8%
Mankind Pharma Ltd. 56,008.27 1,398.15 +2.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.96 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 51.32 3,524.75 +2.1%
Cipla Ltd. Consolidated 2023-03 27.78 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.82 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 84.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.26 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 41.95 1,398.15 +2.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.23 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7.33 3,524.75 +2.1%
Cipla Ltd. Consolidated 2023-03 3.33 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.25 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.19 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 5.39 1,398.15 +2.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 0.04 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,398.15 +2.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 13.10 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,398.15 +2.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 13.10 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,398.15 +2.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,398.15 +2.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,398.15 +2.9%

Bharat Parenterals Ltd. FAQ's

What is Bharat Parenterals share price?
Can I buy Bharat Parenterals shares now?
What is the Dividend Yield of Bharat Parenterals?
What is the Market Cap of Bharat Parenterals?
What are the key metrics to analyse Bharat Parenterals?
What is the 52 Week High and Low of Bharat Parenterals?
What is the trend of Bharat Parenterals share price?